Product Brochure
Process optimization for mAb commercial manufacturing
![Process optimization for mAb commercial manufacturing](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/library/process-optimization-for-mab-commercial-manufacturing/16461569-1-eng-GB/Process-optimization-for-mAb-commercial-manufacturing.jpg)
Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring an existing manufacturing process.
This case study demonstrates advancement of a monoclonal antibody from clinical to commercial phase under a highly compressed timeline.
The presentation highlights the strategic plan Catalent executed to meet the needs of the program without sacrificing the thorough scientific evaluation of the process required for a successful validation campaign.